Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to a *pseudogene* with sequence similarity to the protein-coding YME1-like 1 ATPase (YME1L1)[2][4]. Pseudogenes are DNA sequences homologous to functional genes but typically lack the capability to encode a functional protein product[2][4]. Most pseudogenes arise from gene duplication or retrotransposition events and usually acquire disabling mutations (e.g., premature stop codons, frameshifts)[2][4]. As a pseudogene, ENSG000002243552 is not expressed as a functional protein and is not considered a direct therapeutic target such as an enzyme, receptor, ion channel, or transporter[2][4]. While some pseudogenes are transcribed and may be involved in regulating other genes (e.g., as competitive endogenous RNAs in cancer), there is no evidence that this particular pseudogene has such a role[6]. YME1L1, the functional gene this pseudogene resembles, is an ATP-dependent metalloprotease responsible for mitochondrial protein quality control, morphology, and cell survival—but this function is not attributed to the pseudogene[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ATP-dependent metalloprotease YME1-like 1.